Compare BioNTech SE - ADR (BNTX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Citius Pharmaceuticals Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: BioNTech SE - ADR is far larger — about 1164.9× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| BNTX | CTXR | |
|---|---|---|
Market Cap | $23.31B | $20.01M |
Sector | Health | Health |
52-Week High | $119.34 | $1.82 |
52-Week Low | $83.89 | $0.48 |
Enterprise Value | $6.60B | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
